Doctor profile · Federal record
Dr. AREZOO GHANEIE, MD
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Hematology & Oncology Physician · Hematology & Oncology Physician · WYNNEWOOD, PA
- NPI 1790853497
- Accepts Medicare
- 28 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E LANCASTER AVE STE B20
WYNNEWOOD, PA 190963450
(610) 645-2494
fax (610) 645-4456
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- March 13, 2024
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Pennsylvania #MD422898 · Delaware #C10009263 · New Jersey #25MA08288500
- Medicaid
- PA #1018042430001
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790853497. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,121
Distinct HCPCS
8
Medicare allowed
$108,902
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 2,520 | 13 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 284 | 114 | $94 | |
96372 |
Injection of drug or substance under skin or into muscle | 119 | 26 | $15 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 65 | 65 | $178 | |
J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 56 | 11 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 30 | 20 | $133 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 29 | 13 | $66 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 18 | 18 | $228 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,539. This provider delivers 2.0× the peer median.Open Payments
Industry payments received
All-time total
$3,114
Transactions
106
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $443.20 | |
| Novartis Pharmaceuticals Corporation | 15 | $323.85 | |
| Astellas Pharma US Inc | 9 | $253.63 | |
| PFIZER INC. | 9 | $198.85 | |
| GENZYME CORPORATION | 5 | $197.83 | |
| Eisai Inc. | 8 | $179.26 | |
| Alexion Pharmaceuticals, Inc. | 3 | $149.61 | |
| Lilly USA, LLC | 7 | $147.66 | |
| ABBVIE INC. | 6 | $139.43 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $118.51 | |
| Janssen Biotech, Inc. | 4 | $106.59 | |
| Merck Sharp & Dohme LLC | 5 | $94.27 | |
| GlaxoSmithKline, LLC. | 4 | $82.68 | |
| Genentech USA, Inc. | 3 | $75.13 | |
| Celgene Corporation | 3 | $65.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
317
Patients
48
Total drug cost
$209,011
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 146 | 36 | $3,398 |
| Letrozole | Generic | 46 | 12 | $932 |
| Exemestane | Generic | 27 | 0 | $12,723 |
| Ondansetron Hcl | Generic | 19 | 0 | $110 |
| Eliquis (Apixaban) | Brand | 16 | 0 | $9,360 |
| Prochlorperazine Maleate | Generic | 14 | 0 | $93 |
| Sodium Chloride (0.9 % Sodium Chloride) | Brand | 14 | 0 | $196 |
| Lenalidomide | Generic | 13 | 0 | $181,416 |
| Dexamethasone | Generic | 11 | 0 | $181 |
| Hydroxyurea | Generic | 11 | 0 | $602 |